CONSTRUCTION: Difficulties Abound in Medical Environment
Hospital earthquake planning has kept firms in San Diego like Degenkolb Engineers busy in recent years, the result of seismic retrofit deadlines drawing nearer.
The San Diego company that makes devices and software for sleep issues reported that revenue rose to $601.3 million in the second quarter, a 13 percent year-over-year increase.
Scripps Health will pay $1.5 million to settle allegations related to improper billing for physical therapy services, according to the Justice Department.
The Salk Institute in San Diego has entered into a multi-year partnership with the cancer research company Indivumed, with the goal of turning research into medical applications.
For Illumina, a fairly big announcement recently stemmed from a relatively compact box.
BIOTECH: Co. to Use Blockchain, Cryptocurrency to Build Database
Dawn Barry recently came on board as president of the startup led by former Illumina executives like herself.
The agreement will expand cancer clinical trials and treatment options in the Coachella Valley.
BIOTECH: Platform Interprets Genetic Data for Targeted Cures
The falling cost of sequencing genomes will generate a data tsunami. Edico Genome stands to make sense of much of it.
Dexcom’s technology consists of a sensor that reads glucose levels just beneath the skin.
HEALTH: Aim Is to Prevent Likely Problems, Cut Costs
Amid an aging population, San Diego hospitals have developed senior-focused emergency department services to improve care, with an eye toward their bottom lines.
In 2015, San Diego’s Receptos sold to Celgene for $7.2 billion. Rather than take it easy or go their separate ways, two Receptos’ executives immediately talked of getting the band back together.
The glucose monitoring company's unaudited revenue was $218 million during quarter ending Dec. 31.
Impact Biomedicines was formed around reviving fedratinib, a drug intended to treat a bone marrow disorder and blood cancer.
The company, formed in 2017, is focused on advanced oil extraction methods.
The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.
Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.
After dominating the research market, genomics giant Illumina set its sights on clinics.
NuVasive is poised to keep expanding into 2018, from its balance sheet to its headquarters.
Faheem Hasnain and Sheila Gujrathi — former executives of Receptos — have launched a new San Diego biopharmaceutical company...
TECH: Companies Fear Increase in Costs; Others Dismiss Concerns
The repeal of net neutrality regulations drew opposition from big tech players like Google and Netflix. Also fearing impacts of the move: some San Diego health care businesses.
LAW: Cos. Claim ACA Tax Damages Hiring and R&D
Carlsbad’s Ra Medical Systems is among the medtech companies that say the return of a 2.3 percent excise tax on medical devices sold in the U.S. threatens expansion and hiring plans.
For Dexcom Inc., September brought unwelcome news. As one analyst put it, “The phantom that has been chasing Dexcom has materialized.”
The company’s new 50,000-square-foot facility on Barnes Canyon Road recently became fully operational.
Greenwich Biosciences developed epidolex, a treatment for seizures in two rare, severe childhood-onset epilepsy disorders.
ECONOMY: From Land to Law to Labs, Marijuana Sales Bring Changes, Opportunities
Inside a 1,000-square-foot room, yellow incandescent light filters down on leafy green marijuana plants in neat rows. Soon, plants and lighting will be added vertically — like a double-decker bus — so operator Outco can increase production more than twofold.
Organovo designs and creates functional, three-dimensional human tissues for use in drug discovery, clinical development and therapeutic applications.
HEALTH: Four-Year Deal Brings Retroactive Pay Increases
Both nurse and caregiver unions at Palomar Health recently voted to approve four-year deals with management after seven months of working without a contract.
In 2017, Carlsbad’s Ionis Pharmaceuticals basked in the success of a drug it developed to treat spinal muscular atrophy in infants.
Tocagen brought on Martin “Marty” Duvall as CEO more than a year ago to commercialize its anti-cancer therapies. In 2017, the company marked several milestones on that front.
Robert Hemker, long an architect of Palomar Health District’s financial plans, retired in November.
Under the agreements, 3,000 employees received a retroactive pay raise.
Besting Warren Buffett is a tall order. Under CEO Debra Reed, Sempra did just that.
Pioneering molecular biologist, Elizabeth Blackburn was named Salk’s president in November 2015.
Carlsbad’s Ionis Pharmaceuticals and Biogen have expanded their collaboration to identify new drug candidates for the treatment of spinal muscular atrophy (SMA).
MEDICINE: It Will Seek Closer Ties With UCSD Health, Bolster Marketing
The region’s first and only proton therapy center has relaunched under new ownership and management after a chapter 11 bankruptcy filing protection last spring.
The marine-centric biotech, which has now secured $1.68 million, will use the money to discover potential therapies to treat infectious diseases.
The agreements, which cover more than 3,000 employees who are seven months into working without a contract, must still be ratified.
EDUCATION: School Faces Lawsuit, Changes Marketing
In 2010, for-profit Bridgepoint Education moved to a prominent downtown San Diego high-rise. Its name and logo affixed outside the top floors of 600 B Street symbolized the company’s rapid rise.
The deal, expected to close during the first quarter of 2018, was unanimously approved by both companies’ boards.
In 2002, Rakesh Patel started as a family physician at Neighborhood Healthcare, an organization he now leads.
The lead product candidate is a gene transfer drug to treat heart disease.
Wellness Cos. Help Care and Coverage Providers Find Ways to Effectively Reach and Influence Diverse Customer Bases
Swaying rural teens in Arkansas to stay away from chewing tobacco, a habit ingrained in the local culture, is no easy task. Nor is crafting relatable messages for teens on the dangers of prescription painkiller abuse.
By April the Public Utility Commission of Texas will decide whether to OK Sempra buying Energy Future Holdings, which owns 80 percent of Oncor.
HEALTH: It Will Also Restructure Top Hospital Leadership
Scripps Health will cut corporate services by $30 million and replace the chief executive role at its hospitals with a new leadership model, according to media reports.
Sempra Energy’s $9.45 billion plan to obtain an ownership interest in Texas energy giant Oncor Electric took another step forward on Dec. 12.
The cessation will take effect Feb. 9.
Smithson previously was the vice president of business strategy at the California Life Sciences Association.
The Carlsbad drugmaker has licensed what’s being called a groundbreaking treatment following promising early trial results.
San Diego’s Halozyme Therapeutics will receive a $40 million upfront payment, and potentially much more, as part of a collaboration and licensing deal with Alexion Pharmaceuticals.
San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.